What is Blood Collection Products Market?
Blood collection is the process of taking blood samples from the donor to perform laboratory diagnostic tests and treat patients. It is an essential part of the blood management process in hospitals and blood banking centers. They are used to collect blood samples for testing. The blood collection products are most commonly used to collect blood samples and can also be used as urine collection tubes and as serum separation tubes. These products are essential for diagnostics, surgery, and transfusion procedures. The most common concern of the governments of all nations affected by Covid-19 is the intolerable need to screen and test large numbers of patients for possible Sars-Cov-2 infections. As a result, most of them face significant bottlenecks in the supply of diagnostic kits to test for the virus. Diagnostic virology companies are under immense pressure to provide reliable test kits and the demand for in vitro or point-of-care testing capacity from laboratories in a variety of countries is increasing.
Highlights from Blood Collection Products Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Becton Dickinson (United States), Terumo Corporation (Japan), Greiner Bio-One (Austria), Medtronic (Ireland), SEKISUI Medical (Japan), Sarstedt Group (Germany), Narang Medical (India), F.L. Medical s.r.l (Italy), TUD SDN BHD (Malaysia), Improve Medical (China) and Hongyu Medical (China) |
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Asian Players will contribute to the maximum growth of Global Blood Collection Products market throughout the forecasted period.
Becton Dickinson (United States), Terumo Corporation (Japan), Greiner Bio-One (Austria), Medtronic (Ireland), SEKISUI Medical (Japan), Sarstedt Group (Germany), Narang Medical (India), F.L. Medical s.r.l (Italy), TUD SDN BHD (Malaysia), Improve Medical (China) and Hongyu Medical (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are SANLI Medical & Health Service (China), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China) and Shenzhen Baoan Medical Supply Co., Ltd (China). Blood Collection Products Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Diagnostics and Therapeutics |
Type | Needles & Syringes, Blood Collection Tubes, Blood Bags and Others |
End-User | Hospitals & ASCs,Blood Banks,Diagnostic & Pathology Laboratories |
Collection Method | Manual Blood Collection,Automated Blood Collection |
Collection Type | Venous Blood Collection,Capillary Blood Collection |
On the basis of geography, the market of Blood Collection Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
The Growing Prevalence of Infectious and Non-Infectious Diseases in Various Regions, The Increasing Demand for Biopharmaceutical Plasma for Plasma Fractionation, For Apheresis Devices and Increasing Demand for Blood Components
Market Growth Drivers:
Constant Increase in Accidents and Trauma Cases, The Emergence of Liquid Biopsy Tests and The Established Health Care Industry
Challenges:
Lack of Skilled Professionals
Restraints:
High Cost of Blood Automated Devices
Opportunities:
The Presence of a Large Number of Diagnostic Laboratories and Hospitals, Technological Advancements in Blood Collection Products and The Growing Awareness about Blood Donation through Various Government Initiatives
Key Target Audience
Manufacturers of Blood Collection Products, Suppliers and Distributors of Blood Collection Products, End-Users, Potential Investors, Market Research Firms and Others
Market Leaders & Development Strategies
In April 2021, Terumo Blood and Cell Technologies and CSL Plasma announce a collaboration to deliver a new plasma collection platform
In June 2021, Greiner Bio-One created the MiniCollect PIXIE Heel Incision Safety Lancet, as part of its efforts to diversify its product offerings. There are now three types of lancets to suit a variety of applications.
The Food and Drug Administration (FDA) in the United States is the regulatory body responsible for ensuring the efficacy and safety of blood collection products. The FDA regulates these products under the Center for Biologics Evaluation and Research (CBER), which oversees blood products, including collection devices.